Kantonsspital St.Gallen


Stephan Brand, Jolijn Smolders & Claudia Krieger Grübel

abstract A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active-
Controlled Treat-Through Study of Mirikizumab and Vedolizumab in participants with Moderately to Severely Active Ulcerative Colitis
type of project clinical studies
status completed
start of project 2021
end of project 2024
responsible person Prof. Dr. Stephan Brand